Skip to main content
ADCT
NYSE Life Sciences

ADC Therapeutics Slashes 17% of Workforce, Eyes $10M Annual Savings Amid Zynlonta Focus

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.12
Mkt Cap
$146.27M
52W Low
$0.78
52W High
$4.98
52W Position info
44% above low
Off High info
78% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ADCT sits 44% above its 52-week low of $0.78.

Summary

ADC Therapeutics announced a 17% workforce reduction and company reorganization, aiming to focus resources on its lead cancer drug Zynlonta. This strategic move follows a significant stock plunge earlier this month after the full Phase 3 LOTIS-5 trial data for Zynlonta was released. The company anticipates annual savings of $10 million from these changes, extending its cash runway until at least 2028. A one-time pretax charge of $3 million for severance is expected. The company is preparing for a pre-supplemental Biologics License Application meeting with the FDA in August, with a planned supplemental filing in the fourth quarter.

At the time of this announcement, ADCT was trading at $1.12 on NYSE in the Life Sciences sector, with a market capitalization of approximately $146.3M. The 52-week trading range was $0.78 to $4.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADCT - Latest Insights

ADCT
Nov 09, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.60 info
Change: -$0.146 (-8%) info
Market Cap: $204.268M info
ADCT
Nov 09, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.60 info
Change: +$0.020 (+1%) info
Market Cap: $204.268M info
ADCT
Nov 04, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.60 info
Change: -$0.120 (-7%) info
Market Cap: $204.268M info
ADCT
Nov 03, 2026, 5:02 PM EST
Filing Type: S-4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.60 info
Change: +$0.050 (+3%) info
Market Cap: $204.268M info
ADCT
Oct 13, 2026, 6:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.82
Real-time Price: $1.60 info
Change: -$0.220 (-12%) info
Market Cap: $204.268M info